Dioxaphetyl butyrate

This classification denotes an opioid receptor agonist and opioid and analgesic agent with the molecular formula C22H27NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G751H98FY4, chemically known as 4-morpholinebutyric acid, alpha,alpha-diphenyl-, ethyl ester but more generally known as dioxaphetyl butyrate, which bears US NIH Compound Identifier 48194. European Medicines Agency schedules Dioxaphetyl butyrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07202MIG. The term DIOXAPHETYL BUTYRATE is an International Non-Proprietary Name. Most nations, for tariff and trade purposes, schedule dioxaphetyl butyrate under HS 29349990 and SITC 51579. As of Q4 2014, DIOXAPHETYL BUTYRATE remains US FDA's Preferred Term for this commodity. Dioxaphetyl butyrate bears US NLM identifiers UMLS ID C1880340 and NCI Concept Code C65416. SMILES: CCOC(=O)C(CCN1CCOCC1)(C2CCCCC2)C3CCCCC3.